Tag: 2016

  • Jim Cunningham – 2016 Parliamentary Question to the Department of Health

    Jim Cunningham – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Cunningham on 2016-02-23.

    To ask the Secretary of State for Health, how many grants of what value were made by his Department for meningitis research programmes in each of the last five years.

    George Freeman

    Since 2011, the Department’s National Institute for Health Research (NIHR) has made the following awards through its research programmes and fellowship schemes for research relating to meningitis:

    – Impact of conjugate vaccination on population immunity to pneumococcal and meningococcal disease in England: immunosero-epidemiological analysis (£605,843; 2013-15); and

    – Improving the diagnosis of meningitis in adults in the United Kingdom (£415,242; 2013-16).

    In addition, the NIHR funds research relating to meningitis through:

    – the NIHR Clinical Research Network;

    – NIHR Biomedical Research Centres;

    – NIHR Clinical Research Facilities for Experimental Medicine; and

    – Health Protection Research Units.

    Since 2011, the Department’s Policy Research Programme has made the following award for research relating to meningitis:

    – Characterisation of meningococcal carriage isolates from UK MenCar4 study (£199,990; 2016-17).

  • David Amess – 2016 Parliamentary Question to the Department of Health

    David Amess – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by David Amess on 2016-03-22.

    To ask the Secretary of State for Health, what assessment his Department has made of whether his target of implementing opt-out testing for blood-borne viruses in every adult prison in England by the end of financial year 2016-17 will be met.

    Ben Gummer

    The blood-borne virus (BBV) opt-out testing programme for people in prisons in England is a shared priority for Public Health England (PHE), NHS England and the National Offender Management Service. Programme implementation is overseen by a ‘tripartite’ Task-and-Finish Group which includes third sector and patient voice representation. The roll-out of the programme is informed by phased implementation and evaluation of ‘pathfinder prisons’ over three phases. Phase 1 began on 1 April 2014 and the formal evaluation was published on May 21 2015. Phase 2 pathfinder prisons began implementation from April 2015, with Phase 3 Pathfinders implementing from September 2015. BBV opt-out testing is not limited to only those prisons formally in the pathfinder programme.

    NHS England estimates that currently 60% of the adult prison estate in England are offering opt-out testing and are confident that the target of implementation in every adult prison in England will be achieved by the end of the financial year 2016-17.

  • Alan Whitehead – 2016 Parliamentary Question to the Department for Energy and Climate Change

    Alan Whitehead – 2016 Parliamentary Question to the Department for Energy and Climate Change

    The below Parliamentary question was asked by Alan Whitehead on 2016-04-26.

    To ask the Secretary of State for Energy and Climate Change, what guidance she plans to provide to the oil and gas industry on the definition of satisfactory commercial return used in her Department’s report, Maximising economic recovery strategy for the UK, published in January 2016.

    Andrea Leadsom

    The published MER UK Strategy included, in its annex, a definition of “satisfactory expected commercial return”. Any guidance for industry would be an Oil and Gas Authority matter and they will work with industry to support effective implementation of the MER UK Strategy. The Secretary of State does not intend to issue further guidance.

  • Graham Evans – 2016 Parliamentary Question to the Department for Culture, Media and Sport

    Graham Evans – 2016 Parliamentary Question to the Department for Culture, Media and Sport

    The below Parliamentary question was asked by Graham Evans on 2016-06-06.

    To ask the Secretary of State for Culture, Media and Sport, what steps his Department is taking to accelerate the rollout of broadband in (a) rural and (b) urban areas.

    Mr Edward Vaizey

    The BDUK programme continues to work with BT and other suppliers to bring forward delivery of superfast broadband across the UK. 9 out of 10 homes and businesses can now receive superfast speeds and we remain on track to reach 95% by end of 2017.

  • Louise Haigh – 2016 Parliamentary Question to the HM Treasury

    Louise Haigh – 2016 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Louise Haigh on 2016-09-02.

    To ask Mr Chancellor of the Exchequer, what estimate he has made of the number of cases of each risk type completed by SYNNEX-Concentrix under its contract with HM Revenue and Customs relating to error and fraud.

    Mr David Gauke

    Since mid-October 2015 there has been 120 instances where Concentrix has not fully met the performance standards set out in the contract out of a total of 1625.

    The estimate of commission paid for the HM Revenue and Customs’ contract with SYNNEX-Concentrix relating to error and fraud is £15.8m since the start of the contract to date.

    SYNNEX-Concentrix under its contract with HM Revenue and Customs have completed around 308,718 undeclared partner cases, 198,422 work and hours cases and 152,771 child care cases.

  • Luciana Berger – 2016 Parliamentary Question to the Department of Health

    Luciana Berger – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Luciana Berger on 2016-10-17.

    To ask the Secretary of State for Health, what estimate he has made of the proportion of the population affected by (a) foetal alcohol syndrome and (b) foetal alcohol spectrum disorder in each region of England in each year since 2010.

    Mr Philip Dunne

    The Department has made no estimate of the proportion of the population affected by Foetal Alcohol Syndrome (FAS) or Foetal Alcohol Spectrum Disorders (FASD) in England, regionally or locally.

    The diagnosis for babies born with FAS may not be made easily at birth, and problems may present only later in childhood, for example at school. Estimates for the incidence of FASD are still more uncertain and relate to the lack of consensus on diagnostic criteria for these conditions.

  • Andy Slaughter – 2016 Parliamentary Question to the Ministry of Justice

    Andy Slaughter – 2016 Parliamentary Question to the Ministry of Justice

    The below Parliamentary question was asked by Andy Slaughter on 2016-01-08.

    To ask the Secretary of State for Justice, what assessment he has made of the potential effect of changes to personal injury law and procedure announced in the Spending Review and Autumn Statement 2015 on the number of litigants in person in personal injury claims; and if he will make a statement.

    Dominic Raab

    The Government received and analysed data from numerous sources when formulating the announcement in the Chancellor’s Autumn Statement. We will continue to work with a wide range of stakeholders including other Government Departments, solicitors and insurers in taking forward the new reform package. The Government will consult on the detail of these measures in due course. The consultation will be accompanied by an impact assessment.

  • Karl McCartney – 2016 Parliamentary Question to the Department of Health

    Karl McCartney – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Karl McCartney on 2016-02-02.

    To ask the Secretary of State for Health, what steps his Department and NHS England are taking to ensure that autism diagnosis waiting times for (a) children and (b) adults in Lincolnshire NHS Trust area meet NICE guidance.

    Alistair Burt

    NHS England advises that, from 1 April 2016, Lincolnshire West Clinical Commissioning Group will be commissioning an integrated diagnostic pathway for adults with autism spectrum disorder. Performance measures will include a target maximum 12-week waiting time, to ensure that National Institute for Health and Care Excellence guidelines are met.

    A review of services for children is also planned as part of the Lincolnshire All Age Autism Strategy, which will include the development of a clearly defined integrated pathway for diagnostic assessment and post-diagnostic support for this age group.

  • Ben Bradshaw – 2016 Parliamentary Question to the Department of Health

    Ben Bradshaw – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Ben Bradshaw on 2016-02-23.

    To ask the Secretary of State for Health, who will be consulted during the review of blood donations by the Advisory Committee on the Safety of Blood, Tissues and Organs.

    Jane Ellison

    The Advisory Committee on the Safety of Blood Tissues and Organs (SaBTO) is carrying out a review of blood donor selection criteria. Currently a working group is being formed. The process will fully involve stakeholders, similar to the previous 2011 SaBTO review, and contacting stakeholders inviting their contribution to the review will begin imminently. The terms of reference will include input from stakeholders and be published once approved by SaBTO which will be at their next meeting. The review will be holistic and evidence relating to the risks of blood-borne infections in people who have previously injected drugs or received money or drugs for sex will be included. The review will be incremental, with published progress reports and any intermediate advice.

    It is anticipated that the group will publish its final report in 2017.

  • Dan Jarvis – 2016 Parliamentary Question to the Ministry of Defence

    Dan Jarvis – 2016 Parliamentary Question to the Ministry of Defence

    The below Parliamentary question was asked by Dan Jarvis on 2016-03-22.

    To ask the Secretary of State for Defence, how many partnerships are in operation between UK and non-UK EU-based companies in the area of defence; and what the total value of those partnerships is.

    Mr Julian Brazier

    This information is not held in the format requested.